NASDAQ
iRhythm Technologies, which provides a device and analysis for detecting cardiac arrhythmias, raised $107 million in an upsized IPO by offering 6.3 million shares at $17, above the $13 to $15 range. It had originally planned to raise $75 million by offering 5.4 million shares. iRhythm Technologies plans to list on the Nasdaq under the symbol IRTC. J.P. Morgan and Morgan Stanley acted as lead managers on the deal.
Read More